Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis.
2018.
ncbi.nlm.nih.gov/pmc/articl...
[The researchers present a range of citations. Here we go again: Mg subtypes.]
"...worth noting that high Mg CSF concentrations, in turn, accelerated the formation of α-synuclein oligomers, both from reaction rate and from formation size, that exacerbated dopamine neurons damage and contributed to the progression of PD.47–49 For the future, continuous investigations are necessary to assess the CSF Mg levels of PD patients and expound its impact on the progression of PD."